Drugs / 4G7xH22
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00014560 | Sep 2000 → Feb 2003 | leukemia, lymphoma | Dartmouth-Hitchcock Medical Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4G7xH22 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00014560 ↗ |
| Modality | Monoclonal antibody | “bispecific antibody 4G7xH22” NCT00014560 ↗ |
| Route | Intravenous | “BsAb 4G7xH22 IV over 2 hours” NCT00014560 ↗ |